Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Antares Pharma Inc (NASDAQ:ATRS)

1.84
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
1.58
Today|||52-Week Range
4.09
-21.03%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues14.2M12.0M13.4M15.1M
 
 
 
 
 
Cost of Goods Sold6.2M5.7M5.1M8.0M
 
 
 
 
 
Depreciation And Amortization489.1K493.7K477.8K548.7K
 
 
 
 
 
 
Operating ExpensesGross Income7.5M5.8M7.8M6.5M
 
 
 
 
 
General Expenses11.7M10.6M10.5M11.5M
 
 
 
 
 
Research And Development5.6M3.1M3.2M3.3M
 
 
 
 
 
Total Operating Expenses18.4M16.8M16.1M20.0M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.2M-4.8M-2.7M-4.9M
 
 
 
 
 
Interest Expense On Debt0.000.00--625.9K
 
 
Other Expenses-181.0K29.9K-120.3K119.2K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.4M-4.7M-2.8M-5.5M
 
 
 
 
 
Income Taxes-100.0K0.000.000.00
 
 
Net Income-4.5M-4.7M-2.8M-5.5M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS155.1M155.2M155.9M156.4M
 
 
 
 
 
Shares To Calculate EPS Diluted155.1M155.2M155.9M156.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.03-$0.02-$0.03
 
 
 
 
 
EPS Diluted-$0.03-$0.03-$0.02-$0.03